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of SP cells from humanGBM led to
shortened latency for tumor forma-
tion compared to the main popula-
tion, consistent with SP cells being
enriched for CSCs also in human
tumors.
Taken together, these findings
offer important scientific insight,
and yet seem paradoxical with
respect to their therapeutic impli-
cations. Bleau et al. (2009) showed
that the abundance of the stem-
like glioma cells was readily modi-
fied through either acquisition of
mutation (loss of PTEN) or in
response to treatment with temo-
zolomide (Figure 1). Importantly,
while temozolomide, the most
effective chemotherapy used for
GBM, essentially sets the stage
for recurrent drug-resistant di-
sease, Bleau et al. also demon-
strate that inhibitors of PI3K, now
in clinical trials in cancer, may be
useful in blocking temozolomide-
driven expansion of the SP. These find-
ings also show that the relative abun-
dance and drug resistance of CSCs
can change during malignant pro-
gression and in response to therapy.
Thus acquisition of stemness in cancer
is perhaps more likely a continually
turning ‘‘dial’’ rather than an on/off
‘‘switch.’’ Clearly, future studies are
needed to understand why both loss of
PTEN and temozolomide expand the SP,
and how to translate these findings into
improved therapeutic approaches for
this deadly tumor.
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Figure 1. Models to Describe How Loss of PTEN and
Treatment with Temozolomide May Lead to
Chemoresistance in Glioma
(A) Loss of PTEN leads to increased ABCG2 activity (represented
by black squares) in a subset of cells, resulting in increased self-
renewal and net chemoresistance.
(B) The alkylating agent temozolomide most effectively targets
non-SP cells, leading to relative expansion of a chemoresistant
(ABCG2-positive) SP fraction.
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Recently in Nature Genetics, Wen et al. (2009) report that H3K9me2 modification is more abundant in differ-
entiated cells than in embryonic stem cells and that it decorates chromatin in repressive blocks.A spectrumof differentiated cell types that
constitute higher organisms arise from
pluripotent cells that are found in the inner
cell mass of blastocyst-stage embryos.
Cellular potential is gradually lost as cells
acquire specific fates during development
(Figure 1A), although under certain exper-
imental conditions, their potential can be
reset (via reprogramming, Figure 1A).192 Cell Stem Cell 4, March 6, 2009 ª2009Theexchangeof cellular potential for func-
tional specialization takes place—in
almost all cases—without loss of genetic
material, a result that has led to specula-
tions that progressive silencing of the
genome could underwrite directional
differentiation (Spemann, 1938). Epige-
netic mechanisms capable of modulating
the accessibility of the genome to DNA-Elsevier Inc.binding transcription factors have been
implicated in this process (Reik, 2007),
particularly dynamic changes in DNA
methylation and covalent modification to
histone tails. The importance of these
epigenetic mechanisms for normal devel-
opment is underscored by the prevalence
of lethality among embryos lacking DNA
and histone methyltransferases.
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Figure 1. Epigenetic Modifications Correlate with Lineage Restriction
(A) During development, cellular potential is gradually lost as cells are first committed (blue arrow) to
a specific lineage and subsequently differentiate (green arrow) to generate specialized cell types. Reprog-
ramming (purple arrows) can partially or completely restore potential.
(B) Schematic representation of the distribution of LOCK modifications (red blocks) in pluripotent ESCs
and in differentiated tissues, liver, and brain. The distribution pattern of LOCK modifications in interme-
diate populations has not yet been reported.Chromatin profiling both of specific
candidate loci and also on a genome-
wide scale suggests that peaks of histone
acetylation andmethylation on histone H3
lysine 4 (H3K4me) generally reflect acces-
sible chromatin domains that include
active promoters and enhancers. On the
other hand, methylation of H3K9 and
H3K27 is often associated with repetitive
DNA (for example, satellites), silent or non-
productively expressed loci. Numerous
studies of embryonic stem cells (ESCs)
have shown that these pluripotent cells
harbor chromatin that is poised for tran-
scription and is relatively accessible. For
example, ESCs have high levels of acety-
lated histones (Meshorer et al., 2006),
and many genes encoding transcription
factors that are important for the subse-
quent generation of germ layers are func-
tionally primed, a state that is character-
ized by an abundance of RNA Pol II,
replication early during S phase, and the
simultaneous marking by H3K4me3 and
H3K27me3 (so-called ‘‘bivalent’’ chro-
matin domains) (Reik, 2007; Stock et al.,
2007). Differentiation results in the
silencing of multiple pluripotency-associ-
ated genes, mediated in part by DNA
methylation, and global increases in the
level of DNA methylation and histone
H3K9 trimethylation (a feature of hetero-
chromatin) (Meshorer et al., 2006; Mohn
et al., 2008). In addition, priming of somedevelopmental regulator genes is lost
(Mikkelsen et al., 2007), although theexact
timing of this transition is not known.
Collectively, these studies support the
idea that accessible chromatin, reflecting
the flexible lineage potential of ESCs, is
gradually lost in differentiated cells such
that a developmentally ‘‘committed’’ state
is enforced by more robust (or stable)
gene-silencing mechanisms.
In a recent letter to Nature Genetics,
Wenet al. (2009) examined thedistribution
of methylated H3K9 in ESCs and in differ-
entiated cells using a native chromatin
immunoprecipitation (N-ChIP) approach
coupled with microarrays (Wen et al.,
2009). They found that probes enriched
for dimethylated (H3K9me2) but not trime-
thylated H3K9 (H3K9me3) clustered in
large regions (termed LOCKs, large orga-
nized chromatin K9 modifications) in
terminally differentiated cell types. These
H3K9me2-positive domains covered up
to 46% of the genome (in liver), and
although focused primarily within gene-
sparse regions, they encompassed both
genic and intergenic intervals and showed
an inverse correlation with gene expres-
sion. In ESCs, however, H3K9me2-posi-
tive domains were found to be much less
prevalent in terms of both number and
size (Figure 1B). Interestingly, the authors
also showed that LOCK formation and
repression within differentiated cells wasCell Stem Cdependent on G9a, one of the enzymes
that catalyzes the dimethylation of histone
H3K9. These observations support the
idea that LOCKs are actively established
during differentiation, rather than being
converted from H3K9me3 by histone de-
methylase activity.Of note, other enzymes
involved in metabolism of H3K9me are,
like G9a, required for early embryonic
differentiation or ESC maintenance.
It is tempting to speculate that the
LOCKs—as suggested by their name—
function to irreversibly lock down parts of
the genome that are no longer required as
a cell adopts a certain fate. This proposed
paradigm is reminiscent, albeit less radical,
of the elimination of genetic material that
takes place in ‘‘somatic’’ macronuclei of
the protozoa Tetrahymena, which is also
dependent on H3K9 methylation (Liu
et al., 2004). As the study by Wen et al.
(2009) does not include an analysis
of lineage-restricted stem cells—critical
intermediates between pluripotent and
unipotent cells—it is currently not possible
to decide whether LOCK acquisition more
closely reflects thecommitmentor terminal
differentiation phases of cellular choice.
One of the most intriguing aspects of the
current study is, however, the apparent
overlap between LOCKs and the previ-
ously described lamina-associated
domains (LADs) (Guelen et al., 2008) that
surround the nuclear periphery. Hetero-
chromatin protein 1 (HP1), a protein that
binds methylated H3K9 and is abundant
at the nuclear lamina, may offer the ‘‘link’’
and also help to explain why the silencing
of many genes during mammalian devel-
opment is reported to often occur in close
spatial proximity to the nuclear periphery.
A central question is why, despite a
proliferation of genome-wide H3K9 chro-
matin-profiling studies, have LOCKs not
been widely reported? One possibility is
that algorithms used for data analysis in
previous studies might have been de-
signed to detect narrower peaks rather
than broad H3K9me2-positive domains.
Alternatively, technical differences in the
protocols used for ChIP might offer an
explanation; Wen et al. (2009) used native
conditions (N-ChIP), rather than the more
commonly applied formaldehyde cross-
linking (X-ChIP). The two methods are of
course related and offer distinct advan-
tages and disadvantages (discussed by
O’Neill and Turner, 2003). In particular,
crosslinking can reduce the efficiencyell 4, March 6, 2009 ª2009 Elsevier Inc. 193
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Previewsof precipitation and mask or destroy
epitopes, both of which could result in
a failure to detect modified regions. On
the other hand, under native conditions,
histone-modifying enzymes may remain
active throughout handling, and if
unchecked can degrade samples and
obscure profiling. Whatever the explana-
tion, confirmation and extension of the
LOCK hypothesis is now eagerly awaited
as these molecular studies offer to throw
new light on enduring ideas proposed by
Spemann more than 70 years ago.SP-litting the Sate
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Multiple myogenic populations hav
Tanaka et al. (2009) advance our un
tifying an ABCG2-expressing popula
satellite cell niche.
Tissue-specific stem cells are as sought
after as they are elusive in the pursuit of
effective clinical cell therapy. Empirically,
cell therapy would be the most effective in
tissues that are continually regenerating,
with blood, liver, and muscle cells being
a few that are immediately evident. While
hematopoietic cells have already been
accepted as a therapeutically useful
tissue-specific stem cell, its equivalent
has yet to be identified for repopulating
damaged or diseased muscle. Satellite
cells are myogenic precursor cells located
beneath the basal lamina in myofibers
(Mauro, 1961) and have been shown to
exhibit archetypal stem cell properties
(Collins et al., 2005). However, the engraft-
ment efficiency and capability of isolated
satellitecellshas thus farproven insufficient
to improve muscle function and regenera-
tion. In this issue of Cell Stem Cell, Tanaka
et al. (2009) very elegantly define a novel
population of myogenic precursor cells
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e been highlighted in past publicatio
derstanding of the cells that contribu
tion that exhibits excellent engraftm
that not only possess the ability to differen-
tiate and fuse with myotubes, but when
transplanted, can also regenerate and
maintain a substantial, functional popula-
tion of muscle progenitor cells.
Muscle regeneration has proven to be
a complex process involving multiple
cell lineages. Satellite cells are most
commonly defined by their location within
the basal lamina and their expression of
various myogenic markers such as paired
box gene, Pax7, myoD, and myogenin.
Another population of cells shown to
contribute to regenerating myofibers are
side population (SP) cells, defined by their
dye exclusion properties and which are
found in the interstitium. The majority of
SP cells express theATP-binding cassette
transporter, ABCG2 (Goodell et al., 1996).
Acknowledging the relationship between
satellite cells and SP cells, given that
a coculture of the two will initiate myogen-
esis, Tanaka et al. (2009) sorted a popula-
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te to muscle regeneration by iden-
ent potential, particularly within the
tion of cells that coexpress both Pax7 and
ABCG2. The sort criteria also enriched for
CD34 expression, which is a marker that
identifies cells that are more likely to
engraft when transplanted (Montarras
et al., 2005; Cerletti et al., 2008; Sacco
et al., 2008). Combined, cells expressing
these three markers were enriched within
the Syndecan-3/4-positive pool, and the
population, coined satellite SP cells by
the authors, was shown to spontaneously
differentiate into myotubes in culture.
Additionally, when GFP-marked wild-type
cells were transplanted into mdx mice,
an animal model for dystrophin-deficient
muscular dystrophy, which demonstrates
constant cycles of muscle degeneration
and regeneration, transplanted cells were
able to contribute to sarcolemmal dystro-
phin expression, fusion of myotubes, and
engraftment into the satellite cell niche.
The donor cells engrafted with such high
efficiency that after intramuscular
